A detailed history of Gts Securities LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gts Securities LLC holds 117,700 shares of ABBV stock, worth $19.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
117,700
Previous 110,400 6.61%
Holding current value
$19.7 Million
Previous $18.9 Million 22.75%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $2.32 Million - $2.82 Million
14,143 Added 154.08%
23,322 $4.61 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $1.01 Million - $1.18 Million
6,515 Added 244.56%
9,179 $1.57 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $14.8 Million - $16.8 Million
-92,364 Reduced 97.2%
2,664 $485,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $11.2 Million - $12.6 Million
81,506 Added 602.77%
95,028 $14.7 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $1.81 Million - $2.09 Million
13,522 New
13,522 $2.02 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.